Ibrushil
Ibrushil Products are primarily used for
Blood cancer (Chronic lymphocytic leukemia), Mantle-cell lymphoma
About Ibrushil Products
Uses of Ibrushil Products
Ibrutinib is used in the treatment of blood cancer (chronic lymphocytic leukemia) and mantle-cell lymphoma. It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Ibrushil Products side effects
Common
Side Effects of Ibrushil are Fever, Headache, Fatigue, Musculoskeletal (bone, muscle or joint) pain, Rash, Anemia (low number of red blood cells), Bruising, Muscle spasm, Hemorrhage, Pneumonia, Cough, Diarrhea, Stomatitis (Inflammation of the mouth), Nausea, Low blood platelets, Decreased white blood cell count (neutrophils), Dry eye, High blood pressure, Weight loss, Urinary tract infection, Peripheral edema, Subdural hematoma, Second primary malignancies.
Severe
Side Effect of Ibrushil is Tumor lysis syndrome.
How Ibrushil Products work
Ibrutinib is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Products for Ibrushil
Ibrushil 140mg Capsule
bottle of 30 capsules
MRP
₹8991
Ibrushil 140mg Capsule
bottle of 120 capsules
MRP
₹34920
Not Available